Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nikoletta Zeschick
Observed name:
Zeschick, Nikoletta
Institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen
Observed institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen
ORCID:
0000-0001-8773-3618
Observed ORCID:
0000-0001-8773-3618
OpenAlex ID:
A5112843748
Reactogenicity After Heterologous and Homologous COVID-19 Prime-Boost Vaccination Regimens: Descriptive Interim Results of a Comparative Observational Cohort Study
2021
·
Lisette Warkentin
, Nikoletta Zeschick
, et al.
·
BMC Infectious Diseases
·
15
PDF
Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort study
2023
·
Lisette Warkentin
, Felix Werner
, et al.
·
BMC Medicine
·
12
PDF
Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project
2022
·
Nikoletta Zeschick
, Lisette Warkentin
, et al.
·
Pilot and Feasibility Studies
·
12
PDF
Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study
2023
·
Felix Werner
, Nikoletta Zeschick
, et al.
·
BMC Medicine
·
10
PDF
One year of general practice during the COVID-19 pandemic – presentation and evaluation of digital medical education
2022
·
van der Keylen, Piet
, Zeschick, Nikoletta
, et al.
·
GMS journal for medical education
·
8
PDF
Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany
2022
·
Piet van der Keylen
, Nikoletta Zeschick
, et al.
·
PLoS ONE
·
6
PDF
Verordnungsverhalten von bayerischen Hausärzt*innen an der stationär-ambulanten Schnittstelle vor dem Hintergrund der Bayerischen Wirkstoffvereinbarung – Qualitative Ergebnisse der WirtMed-Studie
2022
·
Nikoletta Zeschick
, Julia Gollnick
, et al.
·
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
·
5
PDF
Controlling Prescribing through “Preferred Drug” Targets—The Bavarian Experience
2024
·
Julia Gollnick
, Nikoletta Zeschick
, et al.
·
International Journal of Environmental Research and Public Health
·
3
PDF
Physicians’ assessment of the Bavarian drug-expenditure control system: a qualitative study
2023
·
Nikoletta Zeschick
, Julia Gollnick
, et al.
·
BMC Health Services Research
·
3
PDF
Surveillance of drug prescribing: why outliers miss their targets – a qualitative study
2025
·
Julia Gollnick
, Nikoletta Zeschick
, et al.
·
BMC Health Services Research
·
1
PDF
Prescribing Vitamin-K-Antagonists Versus Direct Oral Anticoagulants Among Bavarian General Practitioners: A Qualitative Study
2025
·
Nikoletta Zeschick
, Julia Gollnick
, et al.
·
Health Services Insights
Show more works
View as search
Works count:
28
Citation count:
76
H-index:
6
I10-index:
4
Year
Topic
Type